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Abstract
Background As a consequence of the increase in life
expectancy, hepatobiliary surgeons have to deal with an
emerging aged population. We aimed to analyze the liver
function and outcome after right hepatectomy (RH) in
patients over 70 years of age.
Methods From January 2006 to December 2009, we
prospectively collected data of 207 consecutive elective
hepatectomies. In patients who had RH, cardiac risk was
assessed by a dedicated preoperative workup. Liver failure
(LF) was defined by the ‘‘fifty–fifty’’ criteria at postoper-
ative day 5 (POD) and morbidity by the Clavien–Dindo
classification. Liver function tests (LFTs) and short-term
outcome were retrospectively analyzed in patients over
(elderly group, EG) and younger (young group, YG) than
70 years of age.
Results Eighty-seven consecutive RH were performed
during the study period. Indication for surgery included
90 % malignancy in 47 % of patients requiring preoperative
chemotherapy. ASA grade [ 2 (44 vs. 16 %, p = 0.027),
ischemic heart disease (17 vs. 5 %, p = 0.076), and pre-
operative cardiac failure (26 vs. 2 %, p \ 0.001) were more
frequent in the EG (n = 23) than in the YG (n = 64). Both
groups were similar regarding rates of normal liver paren-
chyma, chemotherapy and intraoperative parameters.
The overall morbidity rates were comparable, but the seri-
ous complication (grades III–V) rate was relatively higher
in the EG (39 vs. 25 %, p = 0.199), particularly in patients
with diabetes mellitus (100 vs. 29 %, p = 0.04) and those
who had additional nonhepatic surgery (67 vs. 35 %,
p = 0.110) and transfusions (44 vs. 30 %, p = 0.523). The
90-day mortality rate was similar (9 % in the EG vs. 3 % in
the YG, p = 0.28) and was related to heart failure in the
EG. LFTs showed a similar trend from POD 1 to 8, and
patients C70 years of age had no liver failure.
Conclusions Age C70 years alone is not a contraindica-
tion to RH. However, major morbidity is particularly
higher in the elderly with diabetes. This high-risk group
should be closely monitored in the postoperative course.
Liver function is not altered in the elderly patient after RH.
Introduction
Surgery in the elderly has become very common. In fact,
due to increased life expectancy worldwide [1, 2], hepa-
tobiliary (HPB) surgeons are dealing with an emerging aged
population, which is expected to have a higher risk of
postoperative complications and possibly adverse long-term
outcomes. On the other hand, due to improvement in peri-
operative management, liver surgery is considered safe
today [3], and several series have investigated the outcome
of elderly patients after liver surgery [4–7]. These series
assessed various indications and types of liver resection
together and included patients with various underlying liver
parenchyma. However, the cutoff for age was not always
the same, with a few series using 65 years to define the
elderly population, and others using 70 or even 75 [8–10].
The aging process is a biological reality but its influence
on the function of organs like the liver remains
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controversial. Recently, comparable outcomes in graft
failure and patient survival after transplantation of livers
from donors older or younger than 70 years were reported,
suggesting that liver function is not altered with age
[11–14]. According to published data within the last decade
[9, 10, 15, 16], minor liver resections (i.e., resections of
\3 Couinaud’s segment) can be performed safely in the
elderly whatever the quality of the underlying parenchyma.
In the case of right hepatectomy, the volume of the future
liver remnant (FLR) and the quality of the underlying liver
parenchyma are of primary concern for the postoperative
outcome.
There is some evidence that major hepatectomy is well
tolerated in older patients, however, the mortality risk
ranges from 6 to 10 % in larger series [6, 8, 10, 17]. On the
other hand, the data on the specific risks of right hepatec-
tomy in patients over 70 years of age are scarce and lack
standardization in terms of patient risk assessment, par-
ticularly for cardiac risk. In this setting, two questions are
still debated about elderly patients and are the end points of
our present study: (1) Are the functional reserve and
regenerative capacity of the liver sufficient to tolerate a
parenchymal reduction of 60 % or more? and (2) What is
the impact of a right hepatectomy on postoperative cardiac
function and patient outcome?
Patients and Methods
From January 2006 to December 2009, we prospectively
collected all demographic, clinical, and laboratory data of
patients who underwent elective liver resection in our ter-
tiary referral university center. During the study period, all
consecutive patients older (Elderly group, EG) and younger
(Young group, YG) than 70 years old were assessed with a
dedicated workup before undergoing right or extended
right hepatectomy. Morbidity, mortality, and liver function
were systematically recorded in both groups and data were
analyzed retrospectively. The local ethics committee
approved this study which was registered at ClinicalTri-
al.gov (NCT01471262).
Preoperative Assessment
All treatment strategies and indications for surgery were
discussed by a multidisciplinary board. Before surgery, a
senior HPB surgeon and an anesthetist assessed all patients
in the outpatient clinic. The American Society of Anes-
thesiologists (ASA) grade was used to evaluate the
patients’ operative risk. Preoperative investigations inclu-
ded electrocardiogram and chest radiograph with blood
sampling for all patients (white blood cell count, liver
function tests, and creatinine levels). Preoperative cardiac
risk assessment followed the guidelines for noncardiac
surgery of the European Society of Cardiology (ESC) and
endorsed by the European Society of Anesthesiology
(ESA) [18, 19]. Briefly, the diagnostic algorithm for risk
stratification of myocardial infarction and left ventricular
(LV) function was similar to that proposed for patients in the
nonsurgical setting with known or suspected ischemic heart
disease (IHD). Noninvasive testing included echocardiog-
raphy, exercise electrocardiogram, or stress myocardial
scintigraphy after assessment by a senior cardiologist from
our institution. Invasive testing included coronary angiog-
raphy with corrective intervention if necessary. Preoperative
cardiac failure was defined as left ventricular ejection frac-
tion of\50 % during echocardiography.
Prior to surgery, all patients had a high-resolution con-
trast-enhanced CT scan of the chest and abdomen. The aim
of this imaging was to assess the liver volume, vascular
anatomy, and the extent of the hepatic lesion and to rule out
extrahepatic disease in cases of malignancy. If necessary,
preoperative portal vein embolization (PVE) was per-
formed according to the standard technique [20]. The
indications for PVE included a future remnant liver volume
\25 % in normal parenchyma,\30 % in cases of multiple
cycles of chemotherapy (more than 6), and\40 % in cases
of cirrhosis [21]. Patients with preoperative biliary
obstruction and jaundice underwent percutaneous or
endoscopic drainage prior to surgery. The following pre-
operative characteristics were also analyzed: renal func-
tion, obesity as defined by the World Health Organization
(i.e., BMI C 30 kg/m2) [22], hypertension, diabetes mel-
litus, chronic obstructive pulmonary disease (COPD), and
chemotherapy in patients with malignancy. Renal failure
was defined preoperatively as creatinine clearance below
50 ml/min (Cockcroft formula) or if patients were under
chronic hemodialysis.
Intraoperative Data
Liver resections were classified according to the Brisbane
nomenclature [23]. Right hepatectomy was defined by the
resection of liver Couinaud’s segments V, VI, VII, and
VIII, and extended right hepatectomy was defined by the
resection of additional segments IV and/or I. Extended
right hepatectomy was indicated in patients with an
extensive tumor or vascular invasion. The surgical proce-
dure included parenchyma transection using an ultrasonic
dissector, and intermittent pedicle clamping without pre-
conditioning (Pringle maneuver) was reserved only for the
cases of bleeding. Hemostasis was achieved with bipolar
coagulation, hemoclips, and ligatures.
During parenchymal transection the central venous
pressure was maintained below 5 cmH2O to prevent
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venous hemorrhage and cardiac overload. The following
intraoperative data were also collected: additional nonhe-
patic surgery, intermittent clamping duration, total venous
exclusion of the liver (TVE), need for transfusion, and
operative duration.
Postoperative Care and Outcome Analysis
All patients who underwent a right or extended right hep-
atectomy were transferred postoperatively to the intensive
care unit (ICU) or to the surgical intermediate care unit of
our hospital. This was first to maintain the fluid balance,
second for cardiac monitoring, and third for respiratory
management. Postoperative morbidity was assessed using
the validated classification system by Clavien–Dindo [24].
Serious complications were categorized as grades III–V
and defined as morbidity requiring surgical or radiological
intervention (under local or general anesthesia), ICU
transfer with single- or multiple-organ failure, or death. In
addition, the following specific liver complications were
recorded: postoperative ascites, biliary leak, and liver
failure. Postoperative transaminase (AST and ALT) levels,
total bilirubin (TB) levels, and prothrombin time (PT) were
recorded daily until postoperative day (POD) 8. Liver
failure was defined as a bilirubin level of more than
50 mmol/l and prothrombin index \50 % of normal value
at POD 5 according to the ‘‘fifty–fifty’’ criteria [25].
Postoperative pulmonary morbidity was also analyzed,
including pulmonary embolism (PE), lung infection
requiring intravenous antibiotic therapy with or without
invasive ventilatory support, and pleural effusion requiring
drainage. Postoperative mortality was defined as any death
occurring within 90 days after surgery.
Histopathological Analysis
All liver specimens were sent for histopathological
assessment after surgery. A specialized hepatobiliary
pathologist analyzed the liver lesions and the quality of the
underlying parenchyma. The extent of parenchyma fibrosis
was assessed with the Metavir score [26]. Liver steatosis
was categorized into two groups: less than or more than
30 % micro- or macrovesicular steatosis [27, 28]. Liver
parenchyma with a fibrosis score of F0–F2 and/or with
\30 % steatosis was considered ‘‘normal’’ [28].
Statistical Analysis
The Fisher exact test or the v2 test was used for categorical
variables and the Student t test or one-way ANOVA was
used for continuous variables where appropriate. The
results were expressed as mean and standard deviation
(SD) or median and range. The current clinical relevant
risk factors for major postoperative complications (grade
III–V) in the elderly (i.e., ASA grade, preoperative renal
and cardiac failure, ischemic heart disease, diabetes,
obesity, hypertension, transfusion, additional surgery, and
chemotherapy) were included in the univariate analysis and
proportions were compared according to the two age
groups (C or \70 years old). Statistical analyses were
performed using SPSS for Windows v18 (SPSS Inc., Chi-
cago, IL). Statistical significance was accepted as p \ 0.05
(2-sided tests).
Results
During the study period, a total of 207 consecutive patients
who underwent hepatectomy were collected in the data-
base, including 87 right or extended right hepatectomies,
which correspond to the study cohort (Fig. 1). The median
age was 60 years (range = 21–85) and the male/female
ratio was 55/32. Additional nonhepatic surgery was
required in 33 % of the patients. The main indication for
surgery was malignancy in 90 % (n = 78), including 47 %
who underwent preoperative chemotherapy. Liver paren-
chyma was normal in 78 % of the specimens and the
overall liver failure rate was 5 %. Overall, postoperative
morbidity and 90-day mortality rates were 29 % and
4.6 %, respectively.
Fig. 1 Study population
World J Surg (2012) 36:2161–2170 2163
123
Demographic Characteristics of Patients Younger
and Older than 70 years
Twenty-six percent of the patients (n = 23) were older than
70 years of age. In the EG versus the YG, preoperative
characteristics were comparable, except for the ASA grade,
cardiac failure, and IHD rates, which were higher in the EG
(Table 1). Of note, two patients (9 %) in the EG required
cardiac angiography with dilatation due to significant coro-
nary artery stenosis diagnosed in the preoperative workup.
Indication for surgery was mainly malignancy in both groups
(95 vs. 88 %, p = 0.434), and the rate of preoperative che-
motherapy was similar. In hepatocellular carcinoma (HCC)
patients (n = 21), hepatitis B serology was positive in one
patient [70 years old and in four patients \70 years old.
Hepatitis C serology was negative in all patients[70 years
old and positive in one patient \70 years old. As listed in
Table 2, operating time was not different, with a median of
300 min [interquartile range (IQR) = 230–370] in the EG
versus 270 min (IQR = 225–348) in the YG (p = 0.490).
Total intermittent clamping was also not different, with a
median of 16 min in the EG (IQR = 0–30) versus 23 min in
the YG (IQR = 0–40) (p = 0.565). The rate of additional
nonhepatic surgery was similar between the two groups
(26 % in the EG vs. 36 % in the YG, p = 0.391) and was
always necessary due to local tumor extension. The need for
transfusion was 39 % in the EG versus 42 % in the YG
(p = 0.798). Table 3 summarizes the postoperative out-
comes. The overall complication rate was not different
between the elderly and young patients, but for grades III–V
morbidity tended to be higher in the EG (39 vs. 25 %,
p = 0.199). Of note, there were more cardiac complications
but no liver failures in the EG. The rates of liver- and pul-
monary-related complications were not different between
the two groups. The median hospital stay for the EG was of
17 days (IQR = 13–29) compared with 15 days (IQR =
11–22) for the YG (p = 0.363), and the 90-day mortality rate
was 9 versus 3 % (p = 0.281), respectively. The two deaths
in the EG were due to heart failure. The first fatality was a
patient with an ASA grade of III, cardiac insufficiency, and
IHD, and the second was an ASA III patient with diabetes but
with no previous history of cardiac disease and a normal
preoperative cardiac workup. In the YG, the two deaths were
related to liver failure leading to multiple-organ failure in the
context of cirrhosis. These two patients were 59 and 63 years
old, obese (BMI = 32 and 31, respectively) and with an
ASA grade of III. They both developed HCC secondary to
alcohol-induced cirrhosis and nonalcoholic steatohepatitis
(biopsy-proven), respectively. Serologies for hepatitis B and
C were negative in both cases. Of note, the second patient had
preoperative transarterial chemoembolization (TACE) fol-
lowed by PVE due to a large tumor size (7.5 9 6 cm
diameter). Finally, the future liver remnant volume was 38
and 40 % of the total initial liver volume on the preoperative
Table 1 Demographic characteristics of patients
C70 years
(N = 23)
\70 years
(N = 64)
P value Odds
ratio
95 % CI
Male/female ratio (n) 16/7 42/22 0.41
Median age (range) 75 (70–85) 57 (21–66) \0.001
ASA grade 0.027 4.1 1.4–12
I 4 % 6 %
II 52 % 78 %
III 44 % 16 %
Comorbidities
Renal failure 9 % 3 % 0.274 2.94 0.4–22
Cardiac failure 26 % 2 % 0.001 22.2 2.5–200b
Ischemic heart disease 17 % 5 % 0.076 4.3 0.9–21
COPD 13 % 3 % 0.113 4.6 0.7–29
Diabetes 13 % 11 % 0.72 1.22 0.3–5.2
Hypertension 35 % 34 % 1.0 1.02 0.4–2.8
Obesity 17 % 12 % 0.725 1.47 0.4–5.5
Portal vein embolization 52 % 45 % 0.631 1.31 0.5–3.4
Malignant diseasea 95 % 88 % 0.434
Preoperative chemotherapy 30 % 49 % 0.145 0.4 0.2–1.2
CI confidence interval, COPD chronic obstructive pulmonary disease
a Hepatocellular carcinoma (n = 21), colorectal liver metastases (n = 35), cholangiocarcinoma (n = 8), gallbladder cancer (n = 1), other
metastases (n = 10)
b In small numbers, it is common to have overestimated odds ratio. This result should be taken with caution
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CT scan for EG and YG, respectively. Surgery was
uneventful; however, in two patients a diaphragmatic
resection was required due to tumor invasion. In the post-
operative course, both patients had liver failure according to
the ‘‘fifty–fifty’’ criteria, complicated by infected ascites,
ventilator-associated pneumonia, and hepatorenal syn-
drome. Despite supportive care in the ICU with renal
replacement therapy, both patients died from multiple-organ
failure at days 15 and 31, respectively. In both cases, the
nontumoral liver parenchyma analysis showed cirrhosis with
microvesicular steatosis of more than 40 %.
Additional univariate analysis assessing the factors
associated with major postoperative complications showed
that patients older than 70 years and with diabetes were
particularly at risk for grade III–V complications (Table 4).
In this setting major morbidity was related to one cardiac
failure, one ischemic colon perforation, and one biliary
peritonitis secondary to Roux-en-Y leakage. Of note, there
was a trend toward higher major complications in the
elderly who had additional nonhepatic surgery versus those
who did not (67 vs. 35 %, p = 0.110) and transfusions (44
vs. 30 %, p = 0.523).
Table 2 Intraoperative data
C70 years (%)
(N = 23)
\70 years (%)
(N = 64)
p value Odds ratio 95 % CI
Additional nonhepatic surgery 6 (26) 23 (36) 0.391 0.62 0.2–1.8
Hepaticojejunal anastomosis 4 11
Colectomy 1 1
Diaphragmatic resection 1 5
Vena cava resection 0 1
Portal vein resection 0 1
Othera 0 3
Operative time 300 (IQR 230–370) 270 (IQR 225–348) 0.490 – –
Pedicular clamping 13(65) 41(66) 1.000 0.95 0.3–2.7
Need for transfusions 9(39) 27(42) 0.798 0.88 0.3–2.3
a Adrenalectomy (1), nephrectomy (1), pulmonary wedge resection (1)
Table 3 Postoperative outcome
C70 years (%)
(N = 23)
\70 years (%)
(N = 64)
p value Odds ratio 95 % CI
Minor morbidity (grade I–II)a 3 (13) 8 (12.5) 1.0 1.05 0.2–4.3
Major morbidity (grade III–V)a 9 (39) 16 (25) 0.19 1.92 0.7–5.3
Liver failureb 0 3
Laparotomy (biliary peritonitis/bowel perforation) 2 3
Biliary leak 3 5
ARDS 1 1
Cardiac failure 2 0
Myocardial infarction 1 1
Empyema 0 1
Acute portal vein thrombosis 0 2
Ascites 4 (18) 8 (13) 0.50 1.5 0.4-5.6
Overall biliary leak 3 (14) 11 (17) 1.00 0.76 0.2-3.0
Overall liver failure rate 0 4 (6) 0.57 NAc NAc
Overall pulmonary complications 3 (14) 14 (22) 0.54 0.55 0.1–2.1
90-day mortality 2 (9) 2 (3) 0.28 3 0.4–23
Total hospital stay (days) 17 (IQR = 13–29) 15 (IQR = 11–22) 0.36 – –
a According to Clavien–Dindo classification [24]
b According to the ‘‘fifty–fifty’’ criteria at POD 5 [25]
c Odds ratio could not be calculated because of the presence of a zero in the variables
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Analysis of Liver Function
Liver function tests had a similar trend in both groups
throughout PODs 1–8. At POD 1 versus 8, the median
total bilirubin level was 26 (IQR = 20–43) versus 26
(IQR = 12–35) mmol/l in the EG and 33 (IQR = 26–55)
versus 21 (IQR = 11–50) mmol/l in the YG, respectively
(p = 0.10 and 0.89) (Fig. 2). Similarly, the median pro-
thrombin time was 60 (IQR = 55–70) versus 83
(IQR = 70–90) s in the EG and 60 (IQR = 50–65) versus
85 (IQR = 70–100) s in the YG (p = 0.1 vs. 0.36,
respectively) (Fig. 3). Finally, only ALT levels were sig-
nificantly higher at POD 1 and 3 in the YG (median = 413
vs. 275 mmol/l and 244 vs. 174 mmol/l, p = 0.046 and
p = 0.048, respectively).
Histopathological Analysis
In the elderly versus the young patients, the analysis of
perilesional liver parenchyma showed a similar rate of
normal parenchyma (78 % in both groups, p = 0.991),
with similar rates of F3–F4 fibrosis (22 vs. 19 %,
p = 0.762) and macrovesicular steatosis C30 % (9 vs.
5 %, p = 0.480).
Discussion
The results of our study suggest that age over 70 years
alone is not a contraindication to right hepatectomy. Sur-
gery did not increase the in-hospital mortality when com-
pared to younger patients, and the functional reserve of the
‘‘old liver’’ was not altered. However, major morbidity was
higher in the elderly with diabetes.
Within the last decade, most studies reporting compli-
cations of patients who underwent a hepatectomy included
both major and minor resections, without providing a
subgroup analysis (Table 5). To date, four retrospective
series [6, 8, 10, 17] investigated the outcome of elderly
patients after major hepatectomy. However, it is difficult to
interpret their results for three reasons. First, the preoper-
ative workup used to assess elderly patients was neither
stated nor standardized. Second, the type of major hepa-
tectomy performed was varied and multiple (i.e., it inclu-
ded right and/or left hepatectomies). Third, the cutoff for
age was not always the same (range = 60–75). Our study
provides a homogeneous series of consecutive patients
older and younger than 70 years of age who underwent a
standardized risk assessment workup before formal right
hepatectomy. As expected, elderly patients had more
Table 4 Analysis of predictors for postoperative major morbidity (grades III–V according to the Clavien–Dindo classification [24])
Variable Age
group
No. of
patients
No. complications
[N (%)]
Grades III–V complications
[N (%)]
p value Odds
ratio
95 % CI
ASA [ 2 C70 10 4 (40) 6 (60) 0.1 2.62 0.45–15.31
\70 11 7 (64) 4 (36)
Preoperative renal failure C70 2 1 (50) 1 (50) 0.49 1 0.02–50.4
\70 2 1 (50) 1 (50)
Preoperative cardiac failure C70 6 3 (50) 3 (50) 0.49 NAa NAa
\70 0 0 0
IHD C70 4 3 (75) 1 (25) 0.53 0.67 0.02–18
\70 3 2 (67) 1 (33)
Diabetes C70 3 0 3 (100) 0.04 NAa NAa
\70 7 5 (71) 2 (29)
Obesity C70 2 2 (50) 2 (50) 0.59 3 0.24–37.7
\70 8 6 (75) 2 (25)
Hypertension C70 8 3 (38) 5 (62) 0.17 4.4 0.8–24.6
\70 22 16 (73) 6 (27)
Transfusion C70 9 5 (56) 4 (44) 0.52 1.9 0.4–9
\70 27 19 (70) 8 (30)
Additional surgery C70 6 2 (33) 4 (67) 0.11 6.7 1.04–43.9
\70 23 15 (65) 8 (35)
Chemotherapy C70 7 5 (71) 2 (29) 0.4 1.6 0.24–10.4
\70 30 24 (80) 6 (20)
IHD ischemic heart disease, CI confidence interval
a Odds ratio could not be calculated because of the presence of a zero in the variables
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cardiac comorbidities. Nevertheless, their 90-day mortality
rate was not different than that of younger patients and was
in accordance with the 0–10 % reported rates after major
hepatectomy [5, 6, 8–10, 15, 17]. Of note, the dedicated
workup allowed us to correct potential life-threatening
cardiac disease before hepatic surgery in nearly 10 % of
the elderly patients. Formerly, the most frequently reported
causes of death in the elderly without any underlying dis-
ease were hepatic failure, myocardial infarction, renal
failure, pneumonia, and gastrointestinal bleeding [29–31].
Currently, monitoring a low central venous pressure during
hepatic transection with intraoperative fluid restriction
allowed the reduction of the risk of congestive heart failure
and arrhythmias, which are the most dangerous complica-
tions encountered after major liver resections in the elderly
[8, 10].
Surprisingly, despite the dedicated preoperative workup
and a low central venous pressure maintained during right
hepatectomy in our patients, death was always related
to postoperative cardiac failure in the elderly group.
Fig. 2 Median total bilirubin level (mmol/l) (a) and prothrombin
time (s) (b) from postoperative day 1–8 in patients younger and older
than 70 years of age after right hepatectomy
Fig. 3 Median ALT (mmol/l) (a) and AST (mmol/l) (b) levels from
postoperative day 1 to 8 in patients younger and older than 70 years
of age after right hepatectomy
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These results matched those of other published studies [3,
8] and may be explained by the limited predictive value of
left ventricular (LV) function assessment for perioperative
outcome [19]. Indeed, LV failure predicts with a sensitivity
of 50 % the risk of perioperative nonfatal myocardial
infarction or cardiac death after noncardiac surgery [32].
These results suggest that cardiac risk after right hepatec-
tomy in the elderly should not be underestimated, even
with normal preoperative workup, and that our method of
cardiac assessment should not be withheld but it needs
revision.
After major hepatectomy in the elderly, the reported
complication rate ranges from 30 to 50 % [6, 7, 10]. In our
study, overall morbidity was comparable between the
young and elderly groups. Pulmonary complications were
not different, confirming what was found in previous
reports [17]. This may be explained by the routine use of
postoperative respiratory management and intraoperative
fluid restriction. On the other hand, 39 % of the morbidity
observed in our elderly patients referred to grade III–V
complications. Except of the two cardiac failures that led to
death, all other complications could be managed with ICU
support, surgery, or endoscopic treatment, without affect-
ing the length of in-hospital stay. Interestingly, patients
over 70 years of age and with diabetes had a significantly
increased risk for major complications. It is acknowledged
that patients with diabetes are more prone to sepsis, ath-
erosclerosis, and delayed healing [33]. In addition, patients
with diabetes were associated with delayed ventilator
weaning, more transfusions, and greater morbidity after
liver resections [33, 34]. According to our results, the
morbidity risk after right hepatectomy in patients with
diabetes seems to be amplified by the aging process. We
can speculate that vascular lesions induced by both factors
may be involved in this risk, since most major
complications had an ischemic etiology. As reported by
others [3, 6, 35–37], there was also a trend toward higher
morbidity in the elderly who had additional nonhepatic
surgery or transfusions.
Thus, there is a potentially greater risk for major com-
plications after right hepatectomy in the elderly, but this
morbidity is still acceptable for two reasons: (1) most
patients were operated on for malignancy ([90 % HCC
and colorectal liver metastases) and required a right hep-
atectomy to obtain a tumor-free margin, and (2) most
complications were managed in the same way as in
younger patients, without increasing the mortality risk or
the length of hospital stay. Of note, 33-50 % of the patients
with colorectal liver metastases were older than 70 years
[7]. Moreover, liver resection offers a similar 5-year sur-
vival as that in younger patients [7, 38, 39]. These results
were also confirmed in elderly patients with HCC [15, 16].
Therefore, surgery in the aged population should yield the
same oncological results as in younger patients. To achieve
this goal, a right or extended right hepatectomy may be
necessary. An accepted policy to reduce the postoperative
morbidity in these patients is then to avoid additional
nonhepatic surgery and transfusion whenever possible.
Finally, elderly patients with diabetes should have a dedi-
cated preoperative workup and should be closely moni-
tored postoperatively to anticipate fatal complications,
mainly related to heart failures.
The aging process of the liver is still not fully under-
stood and involves several changes in the liver architecture.
For example, the size of the liver and the sinusoidal flow
decrease with age [40, 41], but their influence on liver
function remains unclear. In our study, the rate of normal
liver parenchyma was similar in patients older and younger
than 70 years of age, suggesting that liver steatosis or
fibrosis was not increase with age. Moreover, liver function
Table 5 Series of hepatectomies in elderly within the past 10 years
Authors [ref] Elderly
(total)
Age
(years)
Main indications Right hepatectomy
rate
Complication
rate (%)
Mortality
rate (%)
Brand et al. [44] 41 [70 CLM Unknown 39 % 7 %
Hanazaki et al. [5] 103 [70 HCC 10 % 28 % 10 %
Ettorre et al. [8] 24 [65 HCC, CLM 100 % 12 % 4 %
Aldrighetti et al. [9] 32 [70 HCC, CLM 34 % 9 % 0
Cescon et al. [17] 23 [70 Multiple 100 % 39 % 0
Yeh et al. [15] 34 [70 HCC Unknown Unknown 8 %
Ferrero et al. [16] 64 [70 HCC 31 % 23 % 3 %
Menon et al. [6] 127 [70 CLM 70 % 31 % 8 %
Adam et al. [7] 1624 [70 CLM Unknown 38 % 4 %
Reddy et al. [10] 322 [65 Multiple 62 % 47 % 6 %
Present study, 2011 23 [70 CLM, HCC 100 % 39 % 9 %
CLM colorectal liver metastases, HCC hepatocellular carcinoma
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tests had a similar trend throughout POD 1–8, confirming
the results reported by Ettorre et al. [8] in patients over
65 years old. We added the ‘‘fifty–fifty’’ criteria [25] to
show that the postoperative liver failure rate was not
increased in patients over 70 years old, provided that liver
parenchyma was prepared by PVE and biliary drainage
when required. These results support the hypothesis that
liver function is not significantly altered with age.
One of the limitations of this study is the small sample
size of elderly patients; however, the incidence of right
hepatectomy in patients over 70 years old is extremely low
in many centers. Another limitation is that in the preop-
erative workup, we did not use (at that time) the indocy-
anine green (ICG) retention test [42, 43]. This test, widely
used in Asian countries and some centers in Europe to
assess liver function, may contribute further to assessing
the postoperative outcome of patients who will undergo a
right hepatectomy as it may correlate with the liver vol-
ume. Well-designed prospective multicenter trials that
include the ICG retention test in the preoperative workup
may further confirm our findings.
In conclusion, the present study confirms that right hep-
atectomy can be performed safely in patients over 70 years
of age without increased morbidity, provided a careful car-
diac and liver parenchyma assessment is performed. How-
ever, the major morbidity will be higher in elderly patients
with diabetes and will tend to increase in those who need
additional nonhepatic surgery or blood transfusions. Finally,
age does not alter significantly the postoperative functional
reserve of the liver. A similar analysis remains to be per-
formed in patients above 80 years of age.
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